Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Growth Metrics
Income Statement
Others
Ratios

Indivior Pharmaceuticals (INDV) Change in Account Payables (2022 - 2024)

Indivior Pharmaceuticals has reported Change in Account Payables over the past 3 years, most recently at -$24.0 million for Q4 2024.

  • For Q4 2024, Change in Account Payables fell 200.0% year-over-year to -$24.0 million; the TTM value through Dec 2024 reached $48.0 million, down 58.26%, while the annual FY2024 figure was $48.0 million, 58.26% down from the prior year.
  • Change in Account Payables for Q4 2024 was -$24.0 million at Indivior Pharmaceuticals, down from $4.0 million in the prior quarter.
  • Over five years, Change in Account Payables peaked at $55.0 million in Q2 2024 and troughed at -$46.0 million in Q3 2022.
  • A 3-year average of $9.4 million and a median of $18.5 million in 2023 define the central range for Change in Account Payables.
  • Biggest five-year swings in Change in Account Payables: skyrocketed 204.35% in 2023 and later crashed 200.0% in 2024.
  • Year by year, Change in Account Payables stood at -$23.0 million in 2022, then skyrocketed by 204.35% to $24.0 million in 2023, then crashed by 200.0% to -$24.0 million in 2024.
  • Business Quant data shows Change in Account Payables for INDV at -$24.0 million in Q4 2024, $4.0 million in Q3 2024, and $55.0 million in Q2 2024.